{"id":671072,"date":"2025-12-25T15:27:18","date_gmt":"2025-12-25T15:27:18","guid":{"rendered":"https:\/\/www.europesays.com\/de\/671072\/"},"modified":"2025-12-25T15:27:18","modified_gmt":"2025-12-25T15:27:18","slug":"wegovy-als-tablette-was-kann-die-abnehmpille-leben-wissen","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/de\/671072\/","title":{"rendered":"Wegovy als Tablette: Was kann die Abnehmpille? | Leben &#038; Wissen"},"content":{"rendered":"<p>Die US-Zulassung von Wegovy als Pille k\u00f6nnte den Abnehmmarkt revolutionieren. Novo Nordisk bringt das Medikament mit dem Wirkstoff Semaglutid Anfang n\u00e4chsten Jahres in Tablettenform auf den Markt, eine attraktive Alternative zu den teuren Spritzen. <\/p>\n<p><b>Wie effektiv die Pille wirklich ist, was die Nachteile sind und ob sie bald auch in Europa erh\u00e4ltlich sein wird, erfahren Sie mit BILDplus.<\/b><\/p>\n","protected":false},"excerpt":{"rendered":"Die US-Zulassung von Wegovy als Pille k\u00f6nnte den Abnehmmarkt revolutionieren. Novo Nordisk bringt das Medikament mit dem Wirkstoff&hellip;\n","protected":false},"author":2,"featured_media":671073,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[134],"tags":[8326,175,170,169,29,6070,7644,30,171,174,18115,18076,45,42606,173,172],"class_list":{"0":"post-671072","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-unternehmen-maerkte","8":"tag-abnehmen","9":"tag-business","10":"tag-companies","11":"tag-companies-markets","12":"tag-deutschland","13":"tag-diabetes","14":"tag-diaet","15":"tag-germany","16":"tag-markets","17":"tag-maerkte","18":"tag-medikamente","19":"tag-ozempic","20":"tag-texttospeech","21":"tag-uebergewicht","22":"tag-unternehmen","23":"tag-unternehmen-maerkte"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@de\/115780914605669831","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/de\/wp-json\/wp\/v2\/posts\/671072","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/de\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/de\/wp-json\/wp\/v2\/comments?post=671072"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/de\/wp-json\/wp\/v2\/posts\/671072\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/de\/wp-json\/wp\/v2\/media\/671073"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/de\/wp-json\/wp\/v2\/media?parent=671072"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/de\/wp-json\/wp\/v2\/categories?post=671072"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/de\/wp-json\/wp\/v2\/tags?post=671072"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}